Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology group

Abstract

Stereotactic body radiotherapy (SBRT) has become treatment option for localized prostate cancer but the evidence base remains incomplete. Several clinical studies, both prospective and retrospective, have been published. However, treatment techniques, target volumes and dose constraints lack consistency between studies. Based on the current available literature, the French Genito-Urinary Group (GETUG) suggests that.

Keywords: Prostatic Neoplasms; Prostatic Neoplasms /radiotherapy; Radiosurgery/methods; Radiotherapy Dosage.